Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis

Verma, 2016, Advances in radiotherapy management of esophageal cancer, J Clin Med, 5, E91, 10.3390/jcm5100091 Chandra, 2005, Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer, Radiother Oncol, 77, 247, 10.1016/j.radonc.2005.10.017 Kole, 2012, Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer, Int J Radiat Oncol Biol Phys, 83, 1580, 10.1016/j.ijrobp.2011.10.053 Fakhrian, 2013, Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk: Planning study in esophageal carcinoma, Strahlenther Onkol, 189, 293, 10.1007/s00066-012-0297-7 Lin, 2012, Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 84, 1078, 10.1016/j.ijrobp.2012.02.015 Lin, 2016, Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer, Cancer, 122, 917, 10.1002/cncr.29857 Wang, 2013, Predictors of postoperative complications after trimodality therapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 86, 885, 10.1016/j.ijrobp.2013.04.006 He, 2016, Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer, Radiother Oncol, 121, 70, 10.1016/j.radonc.2016.08.005 Newhauser, 2015, The physics of proton therapy, Phys Med Biol, 60, R155, 10.1088/0031-9155/60/8/R155 Paganetti, 2013, Biological considerations when comparing proton therapy with photon therapy, Semin Radiat Oncol, 23, 77, 10.1016/j.semradonc.2012.11.002 Zhang, 2008, Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer, Int J Radiat Oncol Biol Phys, 72, 278, 10.1016/j.ijrobp.2008.05.014 Warren, 2016, An analysis of plan robustness for esophageal tumors: Comparing volumetric modulated arc therapy plans and spot scanning proton planning, Int J Radiat Oncol Biol Phys, 95, 199, 10.1016/j.ijrobp.2016.01.044 Lin, 2012, Proton beam therapy and concurrent chemotherapy for esophageal cancer, Int J Radiat Oncol Biol Phys, 83, e345, 10.1016/j.ijrobp.2012.01.003 Takada, 2016, Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer, Cancer Med, 5, 506, 10.1002/cam4.607 Ishikawa, 2015, Proton beam therapy combined with concurrent chemotherapy for esophageal cancer, Anticancer Res, 35, 1757 Zeng, 2016, Proton therapy posterior beam approach with pencil beam scanning for esophageal cancer: Clinical outcome, dosimetry, and feasibility, Strahlenther Onkol, 192, 913, 10.1007/s00066-016-1034-4 Makishima, 2015, Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis, J Radiat Res, 56, 568, 10.1093/jrr/rrv001 2010 Chang, 2014, Clinical implementation of intensity modulated proton therapy for thoracic malignancies, Int J Radiat Oncol Biol Phys, 90, 809, 10.1016/j.ijrobp.2014.07.045 Cooper, 1999, Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group, JAMA, 281, 1623, 10.1001/jama.281.17.1623 Minsky, 2002, INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy, J Clin Oncol, 20, 1167, 10.1200/JCO.2002.20.5.1167 Yu, 2014, Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: Early results of a phase II study, Strahlenther Onkol, 190, 979, 10.1007/s00066-014-0636-y Qi, 2015, Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis, Radiother Oncol, 114, 289, 10.1016/j.radonc.2014.11.033 Patel, 2014, Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: A systematic review and meta-analysis, Lancet Oncol, 15, 1027, 10.1016/S1470-2045(14)70268-2 Shapiro, 2015, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial, Lancet Oncol, 16, 1090, 10.1016/S1470-2045(15)00040-6 Gameiro, 2016, Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to T cell-mediated killing, Int J Radiat Oncol Biol Phys, 95, 120, 10.1016/j.ijrobp.2016.02.022 Davuluri, 2017, Lymphocyte nadir and esophageal cancer survival outcomes following chemoradiotherapy, Int J Radiat Oncol Biol Phys, 99, 128, 10.1016/j.ijrobp.2017.05.037 Welsh, 2011, Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study, Int J Radiat Oncol Biol Phys, 81, 1336, 10.1016/j.ijrobp.2010.07.2001 Conroy, 2014, Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): Final results of a randomised, phase 2/3 trial, Lancet Oncol, 15, 305, 10.1016/S1470-2045(14)70028-2 Ajani, 2008, Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113, J Clin Oncol, 26, 4551, 10.1200/JCO.2008.16.6918 Javeri, 2008, Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus, Cancer, 113, 1302, 10.1002/cncr.23688